LianBio Interest Income (Expense), Net
LianBio (LIANY) reported Interest Income (Expense), Net of $2.71 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNet · last filed 2023-11-13
- LianBio interest income (expense), net for the quarter ending 2023-09-30 was $2.71M, a 92.67% increase year-over-year.
- LianBio interest income (expense), net for the quarter ending 2023-06-30 was $2.75M, a 398.01% increase year-over-year.
- LianBio interest income (expense), net for the quarter ending 2023-03-31 was $2.41M, a 759.29% increase year-over-year.
- LianBio interest income (expense), net for the quarter ending 2022-12-31 was $2.08M, a 2793.06% increase year-over-year.
- LianBio interest income (expense), net for fiscal 2022 was $4.32M, a 1678.19% increase from fiscal 2021.
- LianBio interest income (expense), net for fiscal 2021 was $243.00K.
- LianBio interest income (expense), net for fiscal 2020 was -$4.85M.
| Period end | Interest Income (Expense), Net 3 month | Interest Income (Expense), Net 6 month | Interest Income (Expense), Net 9 month | Interest Income (Expense), Net 12 month |
|---|---|---|---|---|
| 2023-09-30 | $2.71M 10-Q · filed 2023-11-13 | $5.46M derived: sum of 2 quarters · filed 2023-11-13 | $7.87M 10-Q · filed 2023-11-13 | $9.95M derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-06-30 | $2.75M 10-Q · filed 2023-08-14 | $5.16M 10-Q · filed 2023-08-14 | $7.24M derived: sum of 3 quarters · filed 2023-08-14 | $8.65M derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-03-31 | $2.41M 10-Q · filed 2023-05-11 | $4.49M derived: sum of 2 quarters · filed 2023-05-11 | $5.89M derived: sum of 3 quarters · filed 2023-11-13 | $6.45M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-12-31 | $2.08M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $3.49M derived: sum of 2 quarters · filed 2023-11-13 | $4.04M derived: sum of 3 quarters · filed 2023-11-13 | $4.32M 10-K · filed 2023-03-28 |
| 2022-09-30 | $1.41M 10-Q · filed 2023-11-13 | $1.96M derived: sum of 2 quarters · filed 2023-11-13 | $2.24M 10-Q · filed 2023-11-13 | $2.31M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $553.00K 10-Q · filed 2023-08-14 | $833.00K 10-Q · filed 2023-08-14 | $905.00K derived: sum of 3 quarters · filed 2023-08-14 | $937.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $280.00K 10-Q · filed 2023-05-11 | $352.00K derived: sum of 2 quarters · filed 2023-05-11 | $384.00K derived: sum of 3 quarters · filed 2023-05-11 | $490.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $72.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $104.00K derived: sum of 2 quarters · filed 2023-03-28 | $210.00K derived: sum of 3 quarters · filed 2023-03-28 | $243.00K 10-K · filed 2023-03-28 |
| 2021-09-30 | $32.00K 10-Q · filed 2022-11-10 | $138.00K derived: sum of 2 quarters · filed 2022-11-10 | $171.00K 10-Q · filed 2022-11-10 | -$3.40M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $106.00K 10-Q · filed 2022-08-11 | $139.00K 10-Q · filed 2022-08-11 | -$3.44M derived: sum of 3 quarters · filed 2022-08-11 | -$4.73M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $33.00K 10-Q · filed 2022-05-12 | -$3.54M derived: sum of 2 quarters · filed 2022-05-12 | -$4.83M derived: sum of 3 quarters · filed 2022-05-12 | |
| 2020-12-31 | -$3.57M derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-03-31 | -$4.87M derived: sum of 2 quarters · filed 2022-03-31 | -$4.85M 10-K · filed 2022-03-31 | |
| 2020-09-30 | -$1.29M 10-Q/A · filed 2022-01-10 | -$1.28M 10-Q/A · filed 2022-01-10 |